20.56USD-1.98%Mkt Cap: 3.26B USDP/E: —Last update: 2026-06-01
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor p…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.26B USD
Enterprise Value2.39B USD
Revenue (TTM)—
Gross Profit-406.40M USD
Net Income (TTM)-512.54M USD
Revenue/Share—
Last Price20.56 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees507
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS24823R1059
Valuation
P/E (Trailing)—
P/E (Forward)-8.49
PEG—
EV/EBITDA-4.50
EV/Revenue—
P/S—
P/B3.60
EPS (TTM)-2.88
EPS (Forward)-2.48
52W Range
12.5871% of range23.77
52W High23.77 USD
52W Low12.58 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-50.56%
ROA-44.77%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-412.60M USD
CapEx (TTM)9.50M USD
FCF Margin—
FCF Yield-5.84%
Net Debt-947.64M USD
Net Debt/EBITDA1.78
Balance Sheet
Debt/Equity0.04
Current Ratio9.29
Quick Ratio8.98
Book Value/Sh5.837 USD
Cash/Share6.223 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)33.93 USD
Target Range20.00 USD – 42.00 USD
# Analysts15
Ownership
Shares Out.158.71M
Float144.27M
Insiders9.13%
Institutions99.60%
Short Interest
Short Ratio8.2d
Short % Float9.33%
Short % Out.8.84%
Shares Short14.03M
Short (prev mo.)15.28M
Technical
SMA 5019.67 (+4.5%)
SMA 20017.92 (+14.7%)
Beta0.99
S&P 52W Chg27.94%
Avg Vol (30d)1.65M
Avg Vol (10d)1.94M
Technical Indicators
RSI (14)60.5
MACD0.1250
MACD Signal-0.1158
MACD Hist.+0.2409
BB Upper20.98 USD
BB Middle19.35 USD
BB Lower17.72 USD
BB Width16.85%
ATR (14)0.9693 USD
Vol Ratio (20d)0.50x